10 /100
LOW RISK
Score updated Jul 13, 2026

AMRZ — Amrize Ltd Dilution Risk Tracker

Track AMRZ dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AMRZ — Get alerts when the score changes →

As of July 13, 2026, Amrize Ltd (AMRZ) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Amrize Ltd has a market capitalization of $30.11B, 553.54M shares outstanding, 448 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AMRZ.
🔔 Track AMRZ — Get forecast alerts →

💹 Market Data

Market Cap$30.11B
Shares Outstanding553.54M
Float493.20M
Cash$1.10B
Debt$5.27B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 1.6% shares (2026Q1 vs prior)
448 institutional holders · 269.80M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 41.26M shares
#2 BlackRock, Inc. 15.43M shares
#3 DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 12.01M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest8.80M
Days to Cover2.8
% of Float1.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

3 FORM3 Apr 08, 2026
4 INSIDER TRANSACTION Mar 23, 2026
4 INSIDER TRANSACTION Mar 16, 2026
4 INSIDER TRANSACTION Mar 16, 2026
4 INSIDER TRANSACTION Mar 12, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for AMRZ Shareholders

Amrize Ltd (AMRZ) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for AMRZ shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for AMRZ in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for AMRZ alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track AMRZ Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AMRZ — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for AMRZ
📊 AMRZ FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AMRZ Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.